Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
about
Management of sexual dysfunction due to antipsychotic drug therapyManagement of sexual dysfunction due to antipsychotic drug therapyPhosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitusPhosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitusPharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugsOral sildenafil (Viagra) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospitalIndirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunctionModifying Risk Factors in the Management of Erectile Dysfunction: A ReviewThe devil is in the details: an analysis of the subtleties between phosphodiesterase inhibitors for erectile dysfunctionA short review on structure and role of cyclic-3',5'-adenosine monophosphate-specific phosphodiesterase 4 as a treatment toolClinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an updateCurrent use of phosphodiesterase inhibitors in urologyPathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunctionEvolution of penile prosthetic devicesEffect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disordersCharacteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunctionPhenelzine-induced sexual dysfunction treated with sildenafilUps and downs of Viagra: revisiting ototoxicity in the mouse model.The role of hedgehog-interacting protein in maintaining cavernous nerve integrity and adult penile morphologyThe promotion of data sharing in pharmacoepidemiologyThe Drug Repurposing Hub: a next-generation drug library and information resourceTadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US.Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation.Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.Vaginal physiological changes in a model of sexual arousal in anesthetized rats.Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction.Sildenafil inhibits gastroduodenal motility.Sexual aspects of headache. How sexual function relates to headaches and their causes and treatment.Relapse prevention strategies and techniques with erectile dysfunction.Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.Effect of sildenafil on erectile dysfunction in spinal cord injured patients.Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.Manifesto: towards a clinically-oriented psychometrics.Assessment and management of erectile dysfunction in men with diabetes.Sildenafil (Viagra) for the treatment of erectile dysfunction in men with diabetes.Avanafil for male erectile dysfunction: a systematic review and meta-analysis.An open-label study to evaluate sildenafil for the treatment of lymphatic malformations
P2860
Q24197558-FCF8E089-CF9E-424A-A6CD-26C7586458E1Q24246362-064433E0-DC68-433D-90F1-F74A9F6F0D81Q24246544-B8A0B823-BCA0-4F44-85D2-AD7EFD0EDF9AQ24246862-8D5BFACA-D973-4D7F-A3B3-576F51BF63ADQ24672983-B033FB3E-4ECE-4B5C-93EE-2CF2FC0D6DE8Q24807404-13A1375C-5479-452F-A550-521E840EEC58Q25256846-7BE9BC48-DEA3-4609-83E7-11BAD3FFC704Q26737722-6FD4D6CD-5823-42A7-A03C-CE00B77A4BC9Q26747680-D2A27887-1D28-42AF-8292-3E9A74F1A716Q26773564-5424D960-A11A-42AA-A969-912330AD96AAQ26775925-C0BAA9E5-039C-4852-B947-67FFDC40FCC7Q26795512-239A26FA-6D63-4267-AF7A-B36F0845C353Q28067059-1B46005F-B5A6-4CF4-97BC-9E24935C73EBQ28084880-B9D1E77E-AF84-471E-B49D-05F2AE94C74FQ28217534-F0BA5E19-7675-46B8-86AD-97558CC95828Q28269139-6F39DFF5-6CC1-41AF-AA55-63873B30792DQ28344220-9E8CBA00-AE5B-4138-8B37-8D0FBA7A7F6DQ28375888-DB9AC0D1-EDBE-4796-B014-DAD0DB14DFEDQ28535147-BC6CE1E2-C407-49A7-AE90-8EB9C5F33E19Q28583330-DFC9D17A-09BC-437C-A5C0-295A1D724CCEQ28651499-3833092C-91E0-4DD2-A3FE-885BCFBC9BE0Q29363901-F32609B5-7440-45EC-BB72-64BD4A4360A7Q30011021-8B47B47B-8CA4-4CF6-AD29-C1A7730DBAC3Q30558852-5FC1C3BE-98DC-4154-95CA-C6583820E47CQ30617117-1AA06A91-D0D0-43D7-AE47-812AA1B96C14Q30992245-97508BAD-0493-4F21-806F-462C9E8C0319Q31114948-3ADC74B0-159F-468B-9441-148E888B8A3EQ31720367-FEF05B33-653E-4C27-80AE-6FA40B5CDB08Q31811097-F0ED4EF8-0B89-498E-97D1-F9BFBFD086FDQ31992306-A9BF6240-5F1C-4811-89A7-1E25E5435E36Q32064302-E78DBA36-11F7-49F7-BBED-9D949C5F44B1Q33155564-9D1FDECB-0ECA-4E3A-BA48-2814DC3C074BQ33225656-2322EE7C-1BE9-472A-8647-AFCDF7884079Q33605691-840D9B87-6183-4DA5-B051-3DB62B2E8EAFQ33606588-5BE4B828-3D71-4A2A-894F-6B4E92783072Q33608740-70127977-D591-4D0E-B75A-C5F615A7EBC1Q33610338-15AF1A0C-2E79-4986-9E74-A80D99409D3DQ33610343-6A04CC00-676A-44B2-8A07-25598289AAE6Q33621456-31F4E361-B3CA-4C2B-9F22-0CAF15BCD146Q33624856-F21C50A8-3FA4-4CC0-90BB-0355E0731A69
P2860
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@ast
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@en
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@nl
type
label
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@ast
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@en
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@nl
prefLabel
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@ast
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@en
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@nl
P2093
P1476
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
@en
P2093
P304
P356
10.1056/NEJM199805143382001
P407
P577
1998-05-01T00:00:00Z